In the transaction, Apex will sell the assets associated with their hydrogen peroxide BI products and services to Mesa Labs.
Mesa will be relocating the Apex business to its newly acquired SGM Biotech division in Bozeman, Montana, following a brief transition period.
Mesa Labs president and CEO John Sullivan said they are delighted to announce the addition of the Apex line of biological indicators to Mesa’s BI businesses.
"The Apex hydrogen peroxide BI products complement Mesa Labs’ existing line of biological indicators. Apex has captured the major share of this market, due to the excellent customer service and performance characteristics of their hydrogen peroxide BI," Sullivan said.
Now, with the addition of the Apex BI, Mesa will be able to capitalize on the opportunities in this rapidly growing market."
